GUIDA della Società

Norma della sezione 1557 dell'HHS sugli algoritmi clinici

The 2024 HHS Section 1557 rule includes 45 CFR 92.210, requiring covered entities to make reasonable efforts to identify and mitigate discrimination risks from patient care decision support tools.

Ascolta questa guidaNarrato dall'IA · ~3 min

In questa pagina3 minuti di lettura
  1. Panoramica
  2. Immersione profonda
  3. Implementazione nel mondo reale
  4. The Future of HHS Section 1557 Rule on Clinical Algorithms
  5. Metterlo in pratica
  6. Continua a esplorare
  7. Domande frequenti

Panoramica

HHS’s 2026 notice describes partial vacatur of gender-identity provisions; it does not describe §92.210 as vacated.

Immersione profonda

Section 1557 of the Affordable Care Act prohibits discrimination in covered health programs and activities on specified protected grounds. HHS’s 2024 final rule added 45 CFR 92.210 on nondiscrimination in the use of patient care decision support tools. The rule defines these tools broadly to include automated or non-automated methods used by a covered entity to support clinical decision-making, such as screening, risk prediction, diagnosis, treatment planning, health-care operations, and resource allocation as applied to patients. It therefore is not limited to machine-learning models. Covered entities must make reasonable efforts to identify patient care decision support tools that use input variables or factors measuring race, color, national origin, sex, age, or disability, and make reasonable efforts to mitigate the risk that their use discriminates on those bases. The rule does not categorically ban every tool that uses a protected characteristic. HHS states that a covered entity may routinely change tools and did not add a requirement to notify patients about each tool’s training data or assumptions. The legal status must be described carefully. HHS announced in June 2026 that a federal court had vacated specific provisions of the 2024 rule concerning expanded interpretations of sex discrimination tied to gender identity. HHS also said it would continue enforcement of protections involving race, color, national origin, age, disability, and unaffected aspects of sex discrimination. That notice does not say §92.210’s clinical decision-support provision was vacated. Covered entities should monitor court orders and HHS notices rather than assume the entire 2024 rule is either fully enforceable in all respects or entirely void. A covered provider, payer, or health program should inventory patient decision tools, identify which ones use factors related to protected characteristics, assess potential disparate effects, and document reasonable mitigation. Review vendor materials, validate tools for the intended population and setting, monitor performance, and retain a path to correct clinical decisions. Other civil-rights, privacy, device, and state laws may also apply.

Implementazione nel mondo reale

A hospital identifies a risk-scoring tool that uses race-related variables and assesses its effect on care access.

A health plan reviews a utilization-management algorithm and its impact across disability groups.

A provider documents why a decision-support tool is appropriate for its patient population and workflow.

A compliance team distinguishes §92.210 from vacated gender-identity provisions when reading the 2026 HHS notice.

The Future of HHS Section 1557 Rule on Clinical Algorithms

Section 1557 litigation and HHS implementation notices can change which provisions OCR enforces. The June 2026 HHS notice identifies the provisions affected by the Tennessee v. Kennedy judgment and states that other core protections remain in effect. Covered entities should consult the operative regulation, current HHS notices, and specific court orders before making compliance decisions. Track future amendments and update clinical-tool inventories when rules change. The June 2026 notice describes partial vacatur of gender-identity provisions, while stating core protections remain. Check current HHS notices and court orders before applying the rule.

Metterlo in pratica

Perché è importante

  • Rischio e sicurezza. I danni catastrofici e quotidiani dell’IA dipendono entrambi da chi comprende i rischi e da chi può agire.
  • Decisioni più chiare. L’alfabetizzazione pubblica e professionale determina la possibilità politica di una forte politica di sicurezza.
  • Tagliare il clamore. Spiegazioni chiare riducono la cattura da parte di montature pubblicitarie, PR di laboratorio e vaghi teatrini etici.

Attenzione

  • Trattare il rischio esistenziale come fantascienza mentre le capacità si aggravano.
  • Confondere la sicurezza del prodotto superficiale con l'allineamento in condizioni di elevata autonomia.
  • Lasciando il pubblico non inglese e non esperto solo con fonti di bassa qualità.

Prossimi passi

  1. Separare i rischi di danni al prodotto, uso improprio e perdita di controllo/disallineamento.
  2. Chiedi quali prove cambierebbero la tua opinione sulle tempistiche e sulla gravità.
  3. Preferire fonti primarie e valutazioni concrete alle affermazioni di marketing.
  4. Identifica un percorso d’azione: carriera, politica, finanziamenti o competenze, non solo consapevolezza.

Continua a esplorare

Newsletter gratuita

Ricevi il briefing quotidiano sull'IA

Tre storie verificate sull'IA ogni mattina nei giorni feriali, scritte in un inglese semplice. Gratuito per sempre, senza pubblicità.

Un'email ogni giorno feriale. Disiscriviti con un clic. Non vendiamo né condividiamo mai il tuo indirizzo.

Mettiti alla prova

Take the HHS Section 1557 Rule on Clinical Algorithms quiz

Feedback immediato su ogni risposta e un certificato condivisibile con un ID verificabile una volta superato un corso.

Inizia il quiz

Sostieni l'istruzione gratuita sull'IA. AI Understanding è un'organizzazione non profit 501(c)(3) — nessun annuncio, nessun paywall, mai. Fai una donazione

Domande frequenti

What is HHS Section 1557 Rule on Clinical Algorithms?

The 2024 HHS Section 1557 rule includes 45 CFR 92.210, requiring covered entities to make reasonable efforts to identify and mitigate discrimination risks from patient care decision support tools. HHS’s 2026 notice describes partial vacatur of gender-identity provisions; it does not describe §92.210 as vacated.

Quale sezione della regola riguarda gli strumenti di supporto decisionale per la cura del paziente?

The 2024 HHS final rule added §92.210 for nondiscrimination in these tools.

Quali strumenti sono coperti dalla Sezione 92.210?

The definition includes automated and non-automated tools that support clinical decisions.

Cosa devono fare ragionevolmente le entità coperte?

Section 92.210 requires identification and reasonable mitigation.

Did HHS say its June 2026 partial vacatur eliminated §92.210?

HHS described specific provisions affected and other protections remaining.

§92.210 si applica solo a strumenti automatizzati?

HHS defines the tools to include automated and non-automated methods.